Anti-bovine Prion protein RNA aptamer containing tandem GGA repeat interacts both with recombinant bovine prion protein and its β isoform with high affinity

References

• Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993; 90:10962 - 10966
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363 - 13383
   PubMed Web of Science ®Google Scholar
• Marc D, Mercey R, Lantier F. Scavenger, transducer, RNA chaperone? What ligands of the prion protein teach us about its function. Cell Mol Life Sci 2007; 64:815 - 829
   PubMed Web of Science ®Google Scholar
• Wadsworth JD, Collinge J. Update on human prion disease. Biochim Biophys Acta 2007; 1772:598 - 609
   PubMed Web of Science ®Google Scholar
• Hu W, Kieseier B, Frohman E, Eagar TN, Rosenberg RN, Hartung HP, Stuve O. Prion proteins: physiological functions and role in neurological disorders. J Neurol Sci 2008; 264:1 - 8
   PubMed Web of Science ®Google Scholar
• Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346:818 - 822
   PubMed Web of Science ®Google Scholar
• Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249:505 - 510
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang D, Schluesener HJ, Zhang Z. Advances in SELEX and application of aptamers in the central nervous system. Biomol Eng 2007; 24:583 - 592
   PubMedGoogle Scholar
• Mairal T, Ozalp VC, Lozano Sanchez P, Mir M, Katakis I, O'Sullivan CK. Aptamers: molecular tools for analytical applications. Anal Bioanal Chem 2008; 390:989 - 1007
   PubMed Web of Science ®Google Scholar
• Weiss S, Proske D, Neumann M, Groschup MH, Kretzschmar HA, Famulok M, Winnacker EL. RNA aptamers specifically interact with the prion protein PrP. J Virol 1997; 71:8790 - 8797
   PubMed Web of Science ®Google Scholar
• Proske D, Gilch S, Wopfner F, Schatzl HM, Winnacker EL, Famulok M. Prion-protein-specific aptamer reduces PrPSc formation. Chembiochem 2002; 3:717 - 725
   PubMed Web of Science ®Google Scholar
• Rhie A, Kirby L, Sayer N, Wellesley R, Disterer P, Sylvester I, Gill A, Hope J, James W, Tahiri-Alaoui A. Characterization of 2′-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J Biol Chem 2003; 278:39697 - 39705
   PubMed Web of Science ®Google Scholar
• Sayer NM, Cubin M, Rhie A, Bullock M, Tahiri-Alaoui A, James W. Structural determinants of conformationally selective, prion-binding aptamers. J Biol Chem 2004; 279:13102 - 13109
   PubMed Web of Science ®Google Scholar
• Sekiya S, Nishikawa F, Noda K, Kumar PK, Yokoyama T, Nishikawa S. In vitro selection of RNA aptamers against cellular and abnormal isoform of mouse prion protein. Nucleic Acids Symp Ser (Oxf) 2005; 361 - 362
   PubMedGoogle Scholar
• Mercey R, Lantier I, Maurel MC, Grosclaude J, Lantier F, Marc D. Fast, reversible interaction of prion protein with RNA aptamers containing specific sequence patterns. Arch Virol 2006; 151:2197 - 2214
   PubMed Web of Science ®Google Scholar
• Sekiya S, Noda K, Nishikawa F, Yokoyama T, Kumar PK, Nishikawa S. Characterization and application of a novel RNA aptamer against the mouse prion protein. J Biochem 2006; 139:383 - 390
   PubMed Web of Science ®Google Scholar
• Takemura K, Wang P, Vorberg I, Surewicz W, Priola SA, Kanthasamy A, Pottathil R, Chen SG, Sreevatsan S. DNA aptamers that bind to PrP(C) and not PrP(Sc) show sequence and structure specificity. Exp Biol Med (Maywood) 2006; 231:204 - 214
   Google Scholar
• Nishikawa F, Murakami K, Noda K, Yokoyama T, Nishikawa S. Detection of structural changes of RNA aptamer containing GGA repeats under the ionic condition using the microchip electrophoresis. Nucleic Acids Symp Ser (Oxf) 2007; 397 - 398
   PubMedGoogle Scholar
• Bibby DF, Gill AC, Kirby L, Farquhar CF, Bruce ME, Garson JA. Application of a novel in vitro selection technique to isolate and characterise high affinity DNA aptamers binding mammalian prion proteins. J Virol Methods 2008; 151:107 - 115
   Google Scholar
• Ogasawara D, Hasegawa H, Kaneko K, Sode K, Ikebukuro K. Screening of DNA Aptamer Against Mouse Prion Protein by Competitive Selection. Prion 2008; 1:248 - 254
   Web of Science ®Google Scholar
• Fromant M, Blanquet S, Plateau P. Direct random mutagenesis of gene-sized DNA fragments using polymerase chain reaction. Anal Biochem 1995; 224:347 - 353
   PubMed Web of Science ®Google Scholar
• Bagga PS, Wilusz J. Northwestern screening of expression libraries. Methods Mol Biol 1999; 118:245 - 256
   PubMedGoogle Scholar
• Hayashi H, Takata M, Iwamaru Y, Ushiki Y, Kimura KM, Tagawa Y, Shinagawa M, Yokoyama T. Effect of tissue deterioration on postmortem BSE diagnosis by immunobiochemical detection of an abnormal isoform of prion protein. J Vet Med Sci 2004; 66:515 - 520
   PubMed Web of Science ®Google Scholar
• Matsugami A, Ouhashi K, Kanagawa M, Liu H, Kanagawa S, Uesugi S, Katahira M. An intramolecular quadruplex of (GGA)(4) triplet repeat DNA with a G:G:G:G tetrad and a G(:A):G(:A):G(:A):G heptad, and its dimeric interaction. J Mol Biol 2001; 313:255 - 269
   PubMed Web of Science ®Google Scholar
• Laughlan G, Murchie AI, Norman DG, Moore MH, Moody PC, Lilley DM, Luisi B. The high-resolution crystal structure of a parallel-stranded guanine tetraplex. Science 1994; 265:520 - 524
   PubMed Web of Science ®Google Scholar
• Davis JT. G-quartets 40 years later: from 5′-GMP to molecular biology and supramolecular chemistry. Angew Chem Int Ed Engl 2004; 43:668 - 698
   PubMed Web of Science ®Google Scholar
• Balagurumoorthy P, Brahmachari SK, Mohanty D, Bansal M, Sasisekharan V. Hairpin and parallel quartet structures for telomeric sequences. Nucleic Acids Res 1992; 20:4061 - 4067
   PubMed Web of Science ®Google Scholar
• Catasti P, Chen X, Moyzis RK, Bradbury EM, Gupta G. Structure-function correlations of the insulin-linked polymorphic region. J Mol Biol 1996; 264:534 - 545
   PubMed Web of Science ®Google Scholar
• Nandi PK. Interaction of prion peptide HuPrP106-126 with nucleic acid. Arch Virol 1997; 142:2537 - 2545
   PubMed Web of Science ®Google Scholar
• Nandi PK, Nicole JC. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent. J Mol Biol 2004; 344:827 - 837
   PubMed Web of Science ®Google Scholar
• Liu H, Kugimiya A, Matsugami A, Katahira M, Uesugi S. Quadruplex structures of RNA 14-mer, r(GGAGGUUUUGGAGG) and DNA 14-mer, d(GGAGGTTTTGGAGG). Nucleic Acids Res Suppl 2002; 2:177 - 178
   PubMedGoogle Scholar
• Zeiler B, Adler V, Kryukov V, Grossman A. Concentration and removal of prion proteins from biological solutions. Biotechnol Appl Biochem 2003; 37:173 - 182
   Google Scholar
• Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 1983; 35:349 - 358
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE. Purification and structural studies of a major scrapie prion protein. Cell 1984; 38:127 - 134
   PubMedGoogle Scholar
• Caughey B, Raymond GJ, Ernst D, Race RE. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 1991; 65:6597 - 6603
   PubMed Web of Science ®Google Scholar
• Prusiner SB, McKinley MP, Groth DF, Bowman KA, Mock NI, Cochran SP, Masiarz FR. Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci USA 1981; 78:6675 - 6679
   PubMed Web of Science ®Google Scholar
• Luhrs T, Zahn R, Wuthrich K. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions. J Mol Biol 2006; 357:833 - 841
   PubMed Web of Science ®Google Scholar
• Riek R, Hornemann S, Wider G, Glockshuber R, Wuthrich K. NMR characterization of the full-length recombinant murine prion protein, mPrP(23–231). FEBS Lett 1997; 413:282 - 288
   PubMed Web of Science ®Google Scholar
• Gomes MP, Millen TA, Ferreira PS, Cunha ESNL, Vieira TC, Almeida MS, Silva JL, Cordeiro Y. Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells. J Biol Chem 2008; 283:19616 - 19625
   PubMed Web of Science ®Google Scholar
• Davidowitz E, Eljuga L, Dover K, Tian J, Grossman A. Concentration of prion protein from biological samples to increase the limits of detection by immunoassay. Biotechnol Appl Biochem 2005; 41:247 - 253
   PubMed Web of Science ®Google Scholar
• Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810 - 813
   PubMed Web of Science ®Google Scholar
• Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007; 104:9741 - 9746
   PubMed Web of Science ®Google Scholar